Jeco Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.75 M
as on 15-12-2024
- Paid Up Capital ₹ 6.15 M
as on 15-12-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 13.00 Cr
as on 15-12-2024
- Satisfied Charges ₹ 2.08 M
as on 15-12-2024
- Revenue 69.54%
(FY 2021)
- Profit 11.72%
(FY 2021)
- Ebitda -53.09%
(FY 2021)
- Net Worth -4.02%
(FY 2021)
- Total Assets -26.02%
(FY 2021)
About Jeco Life Sciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.75 M and a paid-up capital of Rs 6.15 M.
The company currently has active open charges totaling ₹13.00 Cr. The company has closed loans amounting to ₹2.08 M, as per Ministry of Corporate Affairs (MCA) records.
Jayshree Vora, Atul Vora, and Dhawal Vora serve as directors at the Company.
- CIN/LLPIN
U24100WB2013PTC197078
- Company No.
197078
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jeco Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhawal Vora  | Director | 10-Dec-2016 | Current |
| Jayshree Vora | Director | 06-Sep-2013 | Current |
| Atul Vora | Director | 06-Sep-2013 | Current |
Financial Performance of Jeco Life Sciences.
Jeco Life Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 69.54% increase. The company also saw a substantial improvement in profitability, with a 11.72% increase in profit. The company's net worth dipped by a decrease of 4.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jeco Life Sciences?
In 2021, Jeco Life Sciences had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jeco Feed Chem Private LimitedActive 11 years 4 monthsJayshree Vora, Atul Vora and 1 more are mutual person
- Jeco Nutri Chem Private LimitedActive 20 years 13 days
Jayshree Vora, Atul Vora and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Apr 2022 | ₹13.00 Cr | Open |
Others Creation Date: 30 Aug 2019 | ₹2.08 M | Satisfied |
How Many Employees Work at Jeco Life Sciences?
Unlock and access historical data on people associated with Jeco Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jeco Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jeco Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
